These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 27266998)

  • 1. Design, synthesis, and pharmacological evaluation of multitarget-directed ligands with both serotonergic subtype 4 receptor (5-HT4R) partial agonist and 5-HT6R antagonist activities, as potential treatment of Alzheimer's disease.
    Yahiaoui S; Hamidouche K; Ballandonne C; Davis A; de Oliveira Santos JS; Freret T; Boulouard M; Rochais C; Dallemagne P
    Eur J Med Chem; 2016 Oct; 121():283-293. PubMed ID: 27266998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel multitarget-directed ligands (MTDLs) with acetylcholinesterase (AChE) inhibitory and serotonergic subtype 4 receptor (5-HT4R) agonist activities as potential agents against Alzheimer's disease: the design of donecopride.
    Rochais C; Lecoutey C; Gaven F; Giannoni P; Hamidouche K; Hedou D; Dubost E; Genest D; Yahiaoui S; Freret T; Bouet V; Dauphin F; Sopkova de Oliveira Santos J; Ballandonne C; Corvaisier S; Malzert-Fréon A; Legay R; Boulouard M; Claeysen S; Dallemagne P
    J Med Chem; 2015 Apr; 58(7):3172-87. PubMed ID: 25793650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment.
    Lecoutey C; Hedou D; Freret T; Giannoni P; Gaven F; Since M; Bouet V; Ballandonne C; Corvaisier S; Malzert Fréon A; Mignani S; Cresteil T; Boulouard M; Claeysen S; Rochais C; Dallemagne P
    Proc Natl Acad Sci U S A; 2014 Sep; 111(36):E3825-30. PubMed ID: 25157130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic activation of 5-HT4 receptors or blockade of 5-HT6 receptors improve memory performances.
    Quiedeville A; Boulouard M; Hamidouche K; Da Silva Costa-Aze V; Nee G; Rochais C; Dallemagne P; Fabis F; Freret T; Bouet V
    Behav Brain Res; 2015 Oct; 293():10-7. PubMed ID: 26187692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulating 5-HT
    Lalut J; Karila D; Dallemagne P; Rochais C
    Future Med Chem; 2017 May; 9(8):781-795. PubMed ID: 28504917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel multitarget-directed ligands targeting acetylcholinesterase and σ
    Lalut J; Santoni G; Karila D; Lecoutey C; Davis A; Nachon F; Silman I; Sussman J; Weik M; Maurice T; Dallemagne P; Rochais C
    Eur J Med Chem; 2019 Jan; 162():234-248. PubMed ID: 30447434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, Structure-Activity Relationships, and Preclinical Evaluation of Heteroaromatic Amides and 1,3,4-Oxadiazole Derivatives as 5-HT
    Nirogi R; Mohammed AR; Shinde AK; Gagginapally SR; Kancharla DM; Middekadi VR; Bogaraju N; Ravella SR; Singh P; Birangal SR; Subramanian R; Palacharla RC; Benade V; Muddana N; Jayarajan P
    J Med Chem; 2018 Jun; 61(11):4993-5008. PubMed ID: 29763304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel multi target-directed ligands targeting 5-HT
    Lanthier C; Payan H; Liparulo I; Hatat B; Lecoutey C; Since M; Davis A; Bergamini C; Claeysen S; Dallemagne P; Bolognesi ML; Rochais C
    Eur J Med Chem; 2019 Nov; 182():111596. PubMed ID: 31419776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin 4 receptor (5-HT4R) internalization is isoform-specific: effects of 5-HT and RS67333 on isoforms A and B.
    Mnie-Filali O; Amraei MG; Benmbarek S; Archer-Lahlou E; Peñas-Cazorla R; Vilaró MT; Boye SM; Piñeyro G
    Cell Signal; 2010 Mar; 22(3):501-9. PubMed ID: 19922792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual histamine H3R/serotonin 5-HT4R ligands with antiamnesic properties: pharmacophore-based virtual screening and polypharmacology.
    Lepailleur A; Freret T; Lemaître S; Boulouard M; Dauphin F; Hinschberger A; Dulin F; Lesnard A; Bureau R; Rault S
    J Chem Inf Model; 2014 Jun; 54(6):1773-84. PubMed ID: 24857631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel
    Hatat B; Yahiaoui S; Lecoutey C; Davis A; Freret T; Boulouard M; Claeysen S; Rochais C; Dallemagne P
    Front Aging Neurosci; 2019; 11():148. PubMed ID: 31316368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of serotonin 4 receptor in the growth of hippocampal neurons during the embryonic development in mice.
    Agrawal L; Vimal SK; Shiga T
    Neuropharmacology; 2019 Nov; 158():107712. PubMed ID: 31325432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of 5-HT4 receptors inhibits secretion of beta-amyloid peptides and increases neuronal survival.
    Cho S; Hu Y
    Exp Neurol; 2007 Jan; 203(1):274-8. PubMed ID: 16978609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonin: A New Hope in Alzheimer's Disease?
    Claeysen S; Bockaert J; Giannoni P
    ACS Chem Neurosci; 2015 Jul; 6(7):940-3. PubMed ID: 26011650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and Preclinical Characterization of Usmarapride (SUVN-D4010): A Potent, Selective 5-HT
    Nirogi R; Mohammed AR; Shinde AK; Gagginapally SR; Kancharla DM; Ravella SR; Bogaraju N; Middekadi VR; Subramanian R; Palacharla RC; Benade V; Muddana N; Abraham R; Medapati RB; Thentu JB; Mekala VR; Petlu S; Lingavarapu BB; Yarra S; Kagita N; Goyal VK; Pandey SK; Jasti V
    J Med Chem; 2021 Aug; 64(15):10641-10665. PubMed ID: 34251799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and SAR of Imidazo[1,5-a]pyridine derivatives as 5-HT4 receptor partial agonists for the treatment of cognitive disorders associated with Alzheimer's disease.
    Nirogi R; Mohammed AR; Shinde AK; Bogaraju N; Gagginapalli SR; Ravella SR; Kota L; Bhyrapuneni G; Muddana NR; Benade V; Palacharla RC; Jayarajan P; Subramanian R; Goyal VK
    Eur J Med Chem; 2015 Oct; 103():289-301. PubMed ID: 26363507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationship studies in serotonin 5-HT4 receptor ligands based on a benzo[de][2,6]naphthridine scaffold.
    Castriconi F; Paolino M; Giuliani G; Anzini M; Campiani G; Mennuni L; Sabatini C; Lanza M; Caselli G; De Rienzo F; Menziani MC; Sbraccia M; Molinari P; Costa T; Cappelli A
    Eur J Med Chem; 2014 Jul; 82():36-46. PubMed ID: 24871995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of multiple 5-HT₄ partial agonist clinical candidates for the treatment of Alzheimer's disease.
    Brodney MA; Johnson DE; Sawant-Basak A; Coffman KJ; Drummond EM; Hudson EL; Fisher KE; Noguchi H; Waizumi N; McDowell LL; Papanikolaou A; Pettersen BA; Schmidt AW; Tseng E; Stutzman-Engwall K; Rubitski DM; Vanase-Frawley MA; Grimwood S
    J Med Chem; 2012 Nov; 55(21):9240-54. PubMed ID: 22974325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel 1H-Pyrrolo[3,2-c]quinoline Based 5-HT6 Receptor Antagonists with Potential Application for the Treatment of Cognitive Disorders Associated with Alzheimer's Disease.
    Grychowska K; Satała G; Kos T; Partyka A; Colacino E; Chaumont-Dubel S; Bantreil X; Wesołowska A; Pawłowski M; Martinez J; Marin P; Subra G; Bojarski AJ; Lamaty F; Popik P; Zajdel P
    ACS Chem Neurosci; 2016 Jul; 7(7):972-83. PubMed ID: 27100049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and biological evaluation of new 5-HT4 receptor agonists: application as amyloid cascade modulators and potential therapeutic utility in Alzheimer's disease.
    Russo O; Cachard-Chastel M; Rivière C; Giner M; Soulier JL; Berthouze M; Richard T; Monti JP; Sicsic S; Lezoualc'h F; Berque-Bestel I
    J Med Chem; 2009 Apr; 52(8):2214-25. PubMed ID: 19334715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.